[{"id":"bilcap","kind":"trial","name":"BILCAP","route":"/trials/bilcap/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/spikes/cholangiocarcinoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"ISRCTN registry entry (ISRCTN72785446)\", url: \"https://www.isrctn.com/ISRCTN72785446\" }, { label: \"Primrose et al., Lancet Oncology 2019\", url: \"https://doi.org/10.1016/S1470-2045(18)30915-X\" }]"}]},{"id":"bilcap","kind":"trial","name":"BILCAP","route":"/trials/bilcap/","commit":"06899fbdf4","date":"2026-09-08","author":"Jude Gomila","message":"Spikes: hepatocellular carcinoma, biliary tract cancer, neuroendocrine tumours (deep, with structured outcomes, dosing, toxicity, regulatory","file":"src/data/spikes/cholangiocarcinoma.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"phase"},{"field":"status"},{"field":"yearReported"},{"field":"sponsor"},{"field":"enrolled"},{"field":"setting"},{"field":"tldr"},{"field":"summary"},{"field":"result"},{"field":"outcomes"},{"field":"cancers"},{"field":"technologies"},{"field":"institutions"},{"field":"tags"}]}]